Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of Genomic Variations in Pancreatic Adenocarcinoma by Race. | Cancer Med | 2025 | 41187942 | PubTator, text mining | PubMed |
| Retraction Note: RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma. | BMC Cancer | 2025 | 41131490 | PubTator, text mining | PubMed |
| STT3A is essential for Wnt signaling and represents a target for cancers driven by RNF43 deficiency. | Cell Chem Biol | 2025 | 41130209 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase ZNRF3 restricts WNT receptor complex activity by stimulating the selective degradation of WNT-engaged FZD. | Sci Signal | 2025 | 41086253 | PubTator, text mining | PubMed |
| Wnt induces FZD5/8 endocytosis and degradation and the involvement of RSPO-ZNRF3/RNF43 and DVL. | Elife | 2025 | 41070826 | PubTator, text mining | PubMed |
| Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations. | medRxiv | 2025 | 41030939 | PubTator, text mining | PubMed |
| Adult genomic medicine: lessons from a multisite study of 2700 patients. | Genome Med | 2025 | 41024252 | PubTator, text mining | PubMed |
| Selective and Potent Peptide Binders of RNF43 for Wnt Signaling Inhibition. | ACS Cent Sci | 2025 | 41019111 | PubTator, text mining | PubMed |
| Clinical and Molecular Profiling of Colorectal Cancer: A Comprehensive Cohort Study of BRAF-Mutated Cases from a Tertiary Centre. | Curr Oncol | 2025 | 41002577 | PubTator, text mining | PubMed |
| Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance. | Cells | 2025 | 41002429 | PubTator, text mining | PubMed |
| Low Yield of Genetic Testing in Serrated Polyposis Syndrome. | Clin Transl Gastroenterol | 2025 | 41002021 | PubTator, text mining | PubMed |
| SAG1.3-derived Frizzled-targeting small-molecule compounds. | J Biol Chem | 2025 | 40992662 | PubTator, text mining | PubMed |
| Profilin and Non-Canonical Wnt Signaling: Coordinating Cytoskeletal Dynamics from Development to Disease. | J Dev Biol | 2025 | 40981267 | PubTator, text mining | PubMed |
| JPI-547, a Dual Inhibitor of PARP/Tankyrase, Shows Antitumor Activity Against Pancreatic Cancers with Homologous Recombination Repair Deficiency or Wnt-Addiction. | Int J Biol Sci | 2025 | 40959288 | PubTator, text mining | PubMed |
| A germline variant of ring finger protein 43 in an early onset, treatment-resistant metastatic gastric cancer: a case report. | J Gastrointest Oncol | 2025 | 40950348 | PubTator, text mining | PubMed |
| Precision Oncology Insights into WNT Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer in High-Risk Populations. | Cancers (Basel) | 2025 | 40940930 | PubTator, text mining | PubMed |
| Applying next-generation sequencing to detect microsatellite instability in pan-cancer patients: a retrospective study of 35,563 Chinese cases. | NPJ Precis Oncol | 2025 | 40877495 | PubTator, text mining | PubMed |
| Dual functionality of MDM2 in PROTACs expands the horizons of targeted protein degradation. | Biomark Res | 2025 | 40866949 | PubTator, text mining | PubMed |
| Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives. | J Pers Med | 2025 | 40863456 | PubTator, text mining | PubMed |
| Define a good prognosis of RNF43 codon 659-mutated and concomitant genomic signatures in CRC: an analysis of the cBioPortal database. | Front Oncol | 2025 | 40860811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=4